Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-remifentanil versus isoflurane-remifentanil anesthesia and QTc interval in methadone-maintained surgical patients
IRCT20200524047560N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of propofol, isoflurane, remifentanil and methadone (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: QT interval. Started Sep 2020; status: completed.
02
Drugs
propofolisofluraneremifentanilmethadone
Beyond the preview
Go deeper on IRCT20200524047560N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200524047560N1.